Sort
48,018 grants matching “immunotherapy”
Innovative Research for Cancer Nanotechnology (IRCN) for Enhancing Melanoma-specific Immune Responses by the Rational Design of Spherical Nucleic Acids
$513,840Chad A. Mirkin · Northwestern University · R01 · FY2025 · CA
Modeling based design of chimeric antigen receptors for Natural Killer cell-based immunotherapy
$513,835Stacey Deleria Finley · University Of Southern California · U01 · FY2023 · CA
Targeting Tryptophan Metabolism in Rectal Cancer
$513,828Matthew Aaron Ciorba · Washington University · R01 · FY2023 · CA
Contribution of Cerebral Iron Load to Cognitive Function in Older Adults with High Risk to Develop Alzheimer's Disease
$513,745Ye Qiao · Johns Hopkins University · R01 · FY2023 · AG
Project 1: Evaluating stem-like T cells and improving efficacy of checkpoint inhibitors in NSCLC
$513,707Rafi Ahmed · Emory University · P50 · FY2023 · CA
Breast Cancer Treatment with Antibody Targeted T Cells
$513,661Roger Williams Hospital · R01 · FY2002 · CA
FOXA1 regulates cytokine signaling and immune landscape in prostate cancer through ARID1A
$513,659Jindan Yu · Emory University · R01 · FY2025 · CA
Function of Wdfy4 in cross-presentation and immunity
$513,623Kenneth M. Murphy · Washington University · R01 · FY2021 · AI
Characterizing and Targeting BAX- and BAK-Dependent Cell Death in Cancer
$513,608Emily H Cheng · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA
Characterizing and Targeting BAX- and BAK-Dependent Cell Death in Cancer
$513,608Emily H Cheng · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA
Mechanisms of Lymphomagenesis of Skin Resident Gamma Delta T cells
$513,604Jaehyuk Choi · Northwestern University At Chicago · R01 · FY2022 · CA
Novel CART Cells for Treating AML
$513,445Xianxin Hua · University Of Pennsylvania · R01 · FY2023 · CA
FOXA1 regulates cytokine signaling and immune landscape in prostate cancer through ARID1A
$513,441Jindan Yu · Emory University · R01 · FY2023 · CA
Overcoming stromal barriers to therapeutics in pancreas cancer
$513,401Sunil R Hingorani · Fred Hutchinson Cancer Research Center · R01 · FY2020 · CA
Defining the role of NF1 and SPRED1 loss in melanoma
$513,348Iwei Yeh · University Of California, San Francisco · R37 · FY2025 · CA
DKK2 regulates NK activation and tumor immunity
$513,312Dianqing Wu · Yale University · R01 · FY2020 · CA
DKK2 regulates NK activation and tumor immunity
$513,312Dianqing Wu · Yale University · R01 · FY2021 · CA
DKK2 regulates NK activation and tumor immunity
$513,312Dianqing Wu · Yale University · R01 · FY2018 · CA
Posttranscriptional control of gene expression
$513,285Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Preclinical development and clinical monitoring of adoptive immune therapy
$513,266Jeremy Rose · Division Of Basic Sciences - Nci · ZIC · FY2018 · CA
Targeting replication stress signaling to overcome immune evasion in small cell lung cancer
$513,261Triparna Sen · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA
TECH Core
$513,261Kevin William Eliceiri · University Of Minnesota · U54 · FY2023 · CA
Enhancement of the immune response by Fc modification
$513,256Macrogenics, Inc. · R44 · FY2004 · CA
Reprogramming Exosomes for Novel Immunotherapy of Triple Negative Breast Cancer
$513,250Yong Zhang · University Of Southern California · R01 · FY2025 · CA
ISS-ODN activation of tonsillar APCs to augment immunity
$513,132Melissa J Robbiani · Population Council · R01 · FY2007 · DE